Travere Therapeutics, Inc. · NASDAQ:TVTX
The Vanguard Group reported a 7.75% stake in Travere Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Jan 31, 2025
The Vanguard Group reported a 7.75% stake in Travere Therapeutics, Inc., 6,742,165 shares, as a passive investor on Dec 31, 2024. Filed Jan 31, 2025 (Schedule 13G/A).
- Stake
- 7.75%
- Shares
- 6,742,165
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 7.75% | 6,742,165 |
Source
Related
- Travere Therapeutics, Inc.
- The Vanguard Group
- Travere Therapeutics, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Schedule 13G/A · The Vanguard Group · Jul 29, 2025
- Schedule 13G/A · The Vanguard Group · Apr 30, 2025
- Form 4 · Dube Eric M · Oct 19, 2026
- Form 4 · Heerma Peter · Sep 17, 2026
- Form 4 · Dube Eric M · Sep 17, 2026
- Form 4 · Rote William E. · Sep 17, 2026
- Form 4 · Inrig Jula · Sep 17, 2026